Company No: 16363202 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		30.04.2026
		£
Fixed assets		6,422,761
Current assets		141,578
Creditors: amounts falling due within one year		( 552,843)
Net current liabilities		( 411,265)
Total assets less current liabilities		6,011,496
Creditors: amounts falling due after more than one year		( 5,983,162)
Accruals and deferred income		( 900)
Net assets		27,434
Capital and reserves		27,434

For the financial period ending 30 April 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Formula Botanica Limited (registered number: 16363202) were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

G Moussalli Director

12 October 2026

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 16363202). The address of its registered office is Wadebridge House 16 Wadebridge Square, Poundbury, Dorchester, DT1 3AQ, United Kingdom.

2. Employees

	Period from 03.04.2025 to 30.04.2026
	Number
Monthly average number of persons employed by the Company during the financial period, including directors	3